Oussoren Fieke K, Maldonado Thomas S, Reijnen Michel M P J, Heyligers Jan M M, Akkersdijk G, Attisani L, Bellosta R, Heyligers J M M, Hoencamp R, Garrard L, Maldonado T, Naslund T C, Nolthenius R Tutein, Oderich G S, Ponfoort E D, Reijnen M M P J, Schouten O, Sybrandi J E M, Tenorio E R, Trimarchi S, Verhagen H J M, Veroux P, Wever J, Wiersema A, Wikkeling O R M
Department of Vascular Surgery, Rijnstate Hospital, Arnhem, the Netherlands.
Department of Vascular Surgery, New York University Langone Health, New York, NY.
J Vasc Surg. 2022 Apr;75(4):1268-1275.e1. doi: 10.1016/j.jvs.2021.10.005. Epub 2021 Oct 14.
Isolated iliac artery aneurysms (IAAs), accounting for 2% to 7% of all abdominal aneurysms, are often treated with the use of iliac branched endografts. Although outside the manufacturer's instructions for use, iliac branched devices can be used solely, without the adjunctive placement of an endovascular aneurysm repair device, for the treatment of an isolated IAA. In the present study, we have described the outcomes of the use of the Gore iliac branched endoprosthesis (IBE; W.L. Gore & Associates, Flagstaff, Ariz), without the support of an infrarenal endovascular aneurysm repair device, for the exclusion of an isolated IAA. The present study was an international multicenter retrospective cohort analysis.
All the patients who had undergone treatment with a solitary IBE for IAA exclusion from January 11, 2013 to December 31, 2018 were retrospectively reviewed. The primary outcome was technical success. The secondary outcomes included mortality, intraoperative and postoperative complications, and reintervention.
A total of 18 European and American centers participated, with a total of 51 patients in whom 54 IAAs were excluded. The technical success rate was 94.1%, with an assisted technical success rate of 96.1%. No 30-day mortality occurred, with 98.1% patency of the internal and external iliac artery found at 24 months of follow-up. At 24 months of follow-up, 81.5% of the patients were free of complications and 90% were free of a secondary intervention.
Treatment with a solitary IBE is a safe and, at midterm, an effective treatment strategy for selected patients with a solitary IAA.
